The Clot Thickens Stroke and Thrombosis

Thrombosis and Stroke Resources

Supplementary Reference List: Thrombosis and Stroke Resources. Background reading for trainees and teams building closer collaboration between Stroke, Vascular Medicine and Thrombosis programs.

30 references 8 topics DOI and PubMed links

General Thrombosis

10 references
  1. 01
    Acute treatment of venous thromboembolism.

    Becattini C, Agnelli G.

    Blood. 2020 Jan 30;135(5):305-316.doi:10.1182/blood.2019001881PMID 31917399

  2. 02
    Direct oral anticoagulants: evidence and unresolved issues.

    Chan N, Sobieraj-Teague M, Eikelboom JW.

    Lancet. 2020 Nov 28;396(10264):1767-1776.doi:10.1016/S0140-6736(20)32439-9PMID 33248499

  3. 03
    Deep vein thrombosis and pulmonary embolism.

    Di Nisio M, van Es N, Büller HR.

    Lancet. 2016 Dec 17;388(10063):3060-3073. Epub 2016 Jun 30.doi:10.1016/S0140-6736(16)30514-1PMID 27375038

  4. 04
    Pulmonary embolism: update on management and controversies.

    Duffett L, Castellucci LA, Forgie MA.

    BMJ. 2020 Aug 5;370:m2177.doi:10.1136/bmj.m2177PMID 32759284

  5. 05
    2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

    Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group.

    Eur Heart J. 2020 Jan 21;41(4):543-603.doi:10.1093/eurheartj/ehz405PMID 31504429

  6. 06
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.

    Jervan Ø, Gleditsch J, Tavoly M, Klok FA, Rashid D, Holst R, Steine K, Stavem K, Ghanima W.

    Thromb Res. 2021 Feb 19;201:90-99. Epub ahead of print.doi:10.1016/j.thromres.2021.02.014PMID 33662800

  7. 07
    The problem of under-diagnosis and over-diagnosis of pulmonary embolism.

    Swan D, Hitchen S, Klok FA, Thachil J.

    Thromb Res. 2019 May;177:122-129. Epub 2019 Mar 14.doi:10.1016/j.thromres.2019.03.012PMID 30889517

  8. 08
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.

    Giri J, Sista AK, Weinberg I, Kearon C, Kumbhani DJ, Desai ND, Piazza G, Gladwin MT, Chatterjee S, Kobayashi T, Kabrhel C, Barnes GD.

    Circulation. 2019 Nov 12;140(20):e774-e801. Epub 2019 Oct 4.doi:10.1161/CIR.0000000000000707PMID 31585051

  9. 09
    What's new in the prevention and treatment of cancer-associated thrombosis?

    Kimpton M, Carrier M.

    Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):158-166.doi:10.1182/hematology.2019000023PMID 31808858PMC6913445

  10. 10
    Atrial Fibrillation.

    Michaud GF, Stevenson WG.

    N Engl J Med. 2021 Jan 28;384(4):353-361.doi:10.1056/NEJMcp2023658PMID 33503344

Thrombosis Guidelines

8 references
  1. 01
    American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism.

    Lim W, Le Gal G, Bates SM, Righini M, Haramati LB, Lang E, Kline JA, Chasteen S, Snyder M, Patel P, Bhatt M, Patel P, Braun C, Begum H, Wiercioch W, Schünemann HJ, Mustafa RA.

    Blood Adv. 2018 Nov 27;2(22):3226-3256.doi:10.1182/bloodadvances.2018024828PMID 30482764PMC6258916

  2. 02
    American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

    Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, Shehab N, Mock J, Myers T, Dentali F, Crowther MA, Agarwal A, Bhatt M, Khatib R, Riva JJ, Zhang Y, Guyatt G.

    Blood Adv. 2018 Nov 27;2(22):3257-3291.doi:10.1182/bloodadvances.2018024893PMID 30482765PMC6258922

  3. 03
    American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

    Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, Thurston C, Vedantham S, Verhamme P, Witt DM, D Florez I, Izcovich A, Nieuwlaat R, Ross S, J Schünemann H, Wiercioch W, Zhang Y, Zhang Y.

    Blood Adv. 2020 Oct 13;4(19):4693-4738.doi:10.1182/bloodadvances.2020001830PMID 33007077PMC7556153

  4. 04
    American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

    Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J, Balduzzi S, Darzi A, Morgano GP, Neumann I, Nieuwlaat R, Yepes-Nuñez JJ, Zhang Y, Wiercioch W.

    Blood Adv. 2018 Nov 27;2(22):3198-3225.doi:10.1182/bloodadvances.2018022954PMID 30482763PMC6258910

  5. 05
    American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

    Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, Kahn SR, Rahman M, Rajasekhar A, Rogers FB, Smythe MA, Tikkinen KAO, Yates AJ, Baldeh T, Balduzzi S, Brożek JL, Ikobaltzeta IE, Johal H, Neumann I, Wiercioch W, Yepes-Nuñez JJ, Schünemann HJ, Dahm P.

    Blood Adv. 2019 Dec 10;3(23):3898-3944.doi:10.1182/bloodadvances.2019000975PMID 31794602PMC6963238

  6. 06
    American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.

    Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, Noble S, Sexton EA, Stenehjem D, Wiercioch W, Kahale LA, Alonso-Coello P.

    Blood Adv. 2021 Feb 23;5(4):927-974.doi:10.1182/bloodadvances.2020003442PMID 33570602PMC7903232

  7. 07
    American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

    Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, Vazquez SR, Greer IA, Riva JJ, Bhatt M, Schwab N, Barrett D, LaHaye A, Rochwerg B.

    Blood Adv. 2018 Nov 27;2(22):3317-3359.doi:10.1182/bloodadvances.2018024802PMID 30482767PMC6258928

  8. 08
    American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

    Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N.

    Blood Adv. 2018 Nov 27;2(22):3360-3392.doi:10.1182/bloodadvances.2018024489PMID 30482768PMC6258919

Stroke Etiologies and Antithrombotic Treatment

2 references
  1. 01
    Ischemic Stroke in Young Adults.

    Putaala J.

    Continuum (Minneap Minn). 2020 Apr;26(2):386-414.doi:10.1212/CON.0000000000000833PMID 32224758

  2. 02
    How I treat unexplained arterial thrombosis.

    May JE, Moll S.

    Blood. 2020 Sep 24;136(13):1487-1498.doi:10.1182/blood.2019000820PMID 32584955

Thrombophilias

2 references
  1. 01
    Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.

    Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD.

    J Thromb Thrombolysis. 2016 Jan;41(1):154-64.doi:10.1007/s11239-015-1316-1PMID 26780744PMC4715840

  2. 02
    Current Practice and Clinical Utility of Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke.

    May JE, Martin KD, Taylor LJ, Gangaraju R, Lin C.

    J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105209. Epub 2020 Aug 17.doi:10.1016/j.jstrokecerebrovasdis.2020.105209PMID 33066926

Antiphospholipid Antibody Syndrome

3 references
  1. 01
    Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.

    Devreese KMJ, de Groot PG, de Laat B, Erkan D, Favaloro EJ, Mackie I, Martinuzzo M, Ortel TL, Pengo V, Rand JH, Tripodi A, Wahl D, Cohen H.

    J Thromb Haemost. 2020 Nov;18(11):2828-2839.doi:10.1111/jth.15047PMID 33462974

  2. 02
    Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

    Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A.

    Blood. 2018 Sep 27;132(13):1365-1371. Epub 2018 Jul 12.doi:10.1182/blood-2018-04-848333PMID 30002145

  3. 03
    Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.

    Ordi-Ros J, Sáez-Comet L, Pérez-Conesa M, Vidal X, Riera-Mestre A, Castro-Salomó A, Cuquet-Pedragosa J, Ortiz-Santamaria V, Mauri-Plana M, Solé C, Cortés-Hernández J.

    Ann Intern Med. 2019 Nov 19;171(10):685-694. Epub 2019 Oct 15.doi:10.7326/M19-0291PMID 31610549

Myeloproliferative Neoplasms

1 reference
  1. 01
    Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.

    Tefferi A, Barbui T.

    Am J Hematol. 2020 Dec;95(12):1599-1613. Epub 2020 Oct 23.doi:10.1002/ajh.26008PMID 32974939

Stroke and Malignancy

3 references
  1. 01
    Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.

    Shah S, Norby FL, Datta YH, Lutsey PL, MacLehose RF, Chen LY, Alonso A.

    Blood Adv. 2018 Feb 13;2(3):200-209.doi:10.1182/bloodadvances.2017010694PMID 29378726PMC5812321

  2. 02
    Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.

    Martinez-Majander N, Ntaios G, Liu YY, Ylikotila P, Joensuu H, Saarinen J, Perera KS, Marti-Fabregas J, Chamorro A, Rudilosso S, Prats-Sanchez L, Berkowitz SD, Mundl H, Themeles E, Tiainen M, Demchuk A, Kasner SE, Hart RG, Tatlisumak T; NAVIGATE ESUS investigators.

    Eur J Neurol. 2020 May;27(5):841-848. Epub 2020 Mar 11.doi:10.1111/ene.14172PMID 32056346

  3. 03
    Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review.

    Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, Smeeth L, Bhaskaran K.

    BMJ. 2018 Oct 8;363:k3845.doi:10.1136/bmj.k3845PMID 30297439PMC6174332

Endocarditis

1 reference
  1. 01
    Coagulation: At the heart of infective endocarditis.

    Liesenborghs L, Meyers S, Vanassche T, Verhamme P.

    J Thromb Haemost. 2020 May;18(5):995-1008. Epub 2020 Feb 3.doi:10.1111/jth.14736PMID 31925863

Podcast episode

How to implement close collaborations between thrombosis and stroke services

Watch the episode